Neuberger High Yield Strategies Fund Inc. (NHS) Fund Overview
Neuberger High Yield Strategies Fund Inc. (NHS) — price $5.30 (-0.47%), as of the Nov 19, 2026 trading session.
Educational signal · not a buy or sell recommendation · How to read this
Neuberger High Yield Strategies Fund Inc. · NHS
Neuberger High Yield Strategies Fund Inc. Managed by Neuberger Berman Investment Advisers LLC, its objective is to generate high current income for investors.
Price as of Nov 19, 2026
Key Statistics
Not scored: this is a debt/preferred or other non-common instrument, or its reported market value does not match its share basis.
Price & valuation
| Measure | Value |
|---|---|
| Latest provided price | $5.30 |
| Change on the day | -0.47% |
| Price / earnings (trailing) | 8.92 |
| Shares traded on the day | 261.0K |
Price & events
Other perspectives
Council score for Neuberger High Yield Strategies Fund (NHS): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Legends Council
4 lenses, 0 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Sep 10, 2026 · older than the 27 hours refresh window; not a current reading
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: May 1, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
On May 1, 2026, the Munger lens read the price at that time as undervalued against its own estimate of value.
Readings on this page are from Nov 20, 2026, except a card that shows its own read date.
What is Neuberger High Yield Strategies Fund (NHS), and what does it report?
Short answer · as of
A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. Neuberger High Yield Strategies Fund Inc. (NHS) is the company analyzed here. In Q2 FY2026 it reported revenue of $11M and net income of $4M.
What do the latest results show for Neuberger High Yield Strategies Fund (NHS)?
Short answer · as of
The most recent reported quarter, Q2 FY2026, carried revenue of $11M.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q2 FY2026 | $11M | $4M | $0.05 (diluted) |
| Q4 FY2025 | $15M | $17M | $0.55 (diluted) |
| Q2 FY2025 | $12M | $3M | $0.11 (diluted) |
| Q4 FY2024 | $11M | $15M | $0.46 (diluted) |
What are the financial strengths and risks for Neuberger High Yield Strategies Fund (NHS)?
Short answer · as of
The distress and quality screens read Altman Z 0.81 · Piotroski F 4. Trailing ratios: ROE 8.1% · ROA 4.9% · current ratio 1.79 · earnings yield 4.8% · free-cash-flow yield 9.5%.
The records behind this page
Who holds the shares?
Institutional ownership reported through 13F filings.
Tracked investors
Which of the 16 named investors we follow held NHS in their latest 13F filing, and what they did against the filing before it.
None of the 16 tracked investors reported NHS in their latest 13F filing.
How to read these figures
These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.
What has been published about Neuberger High Yield Strategies Fund (NHS)?
Neuberger High Yield Strategies Fund Stock: Key Questions Answered
These answers are editorial: 1 of these 1 answer is drawn from the NHS research dossier (written Jun 14, 2026 by gemini-2.5-flash). Figures in this section are not part of the source register.
What are the key characteristics of a closed-end fund like NHS that investors may want to evaluate?
As a closed-end fund, NHS possesses several distinct characteristics important for investors. Firstly, it issues a fixed number of shares that trade on a stock exchange, similar to common stocks. This means its market price can fluctuate independently of its Net Asset Value (NAV), often trading at a premium or discount to its underlying asset value.
Machine-generated analysis by Stock Expert AI — model gemini-2.5-flash, generated Jun 14, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources: the source register lists the 10 figures on this page — 8 from Financial Modeling Prep (FMP) and 2 with no recorded source. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.
Publication details and research sources
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com